Carvedilol

xPharm: The Comprehensive Pharmacology Reference

Volumn , Issue , 2007, Pages 1-5

  Wagner, Linda ^a   Kenreigh, Charlotte ^a  

^a MLC Solutions LTD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884038284     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-008055232-3.61391-1     Document Type: Chapter

References (9)

1. Bristow M.R., Larrabee P, Muller-Beckmann B., Minobe W., Roden R., Skerl L., Klein J., Handwerger D., Port J.D. Effects of carvedilol on adrenergic receptor pharmacology in human ventricular myocardium and lymphocytes. Clin. Invest. 1992, 70(Suppl. 1):S105-S113.
2. Tenero D., Boike S., Boyle D., Ilson B., Fesniak H.F., Brozena S., Jorkasky D. Steady-state pharmacokinetics of carvedilol and its enantiomers in patients with congestive heart failure. J. Clin. Pharmacol. 2000, 40(8):844-853.
3. McEvoy G.K. AHFS Drug Information 2004 2004, 1746-1748. American Society of Health-System Pharmacists, Inc, Bethesda, MD. G.K. McEvoy (Ed.).
4. O'Neil M.J. The Merck Index 2001, 318. Merck and Co., Inc., Whitehouse Station, NJ. Edition 13. M.J. O'Neil (Ed.).
5. Hoffman B.B. Catecholamine, Sympathomimetic Drugs & Adrenergic Receptor Antagonists. Goodman and Gilman's The Pharmacological Basis of Therapeutics 2001, 255, 1936. Macmillan Publishing Co., New York, NY. Edition 10. J.G. Hardman, L.E. Limbird, A.G. Gilman (Eds.).
6. Hutchinson T.A., Shahan D.R. DrugDexX System. MicroMedex 2003, Greenwood Village, CO. Edition 121. T.A. Hutchinson, D.R. Shahan (Eds.).
7. Package Insert Coreg Package Insert Coreg 2003, GlaxoSmithKline.
8. A review of the pharmacology of carvedilol:.
9. Dulin, B. and Abraham, W.T., Pharmacology of carvedilol, Amer. J. Cardiol., 93 (9 Suppl. 1) (2004) 3-6.